Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Chr. Olesen Synthesis

Chr. Olesen Synthesis?uq=UG6efJS6
2012 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$11.2M LATEST DEAL AMOUNT
1 INVESTORS
Description

Manufacturer of active pharmaceutical ingredients designed to produce controlled substances comprising semi-synthetic opioids. The company's active pharmaceutical ingredients include Hydromorphone, Codeine Phosphate, Amphetamine derivatives and advanced intermediates for Buprenorphine and Tamsulosin, with variety of chemical synthetic methods in multi-step reactions, enabling clients to avail the advanced intermediates of APIs.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • J√¶gersborg Alle 164
  • 2820 Gentofte
  • Denmark
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Chr. Olesen Synthesis’s full profile, request a free trial.

Chr. Olesen Synthesis Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 08-Oct-2015 $11.2M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Chr. Olesen Synthesis Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 01-Jan-2011 000000000 Distributors (Healthcare)
To view this company’s complete investment and acquisition history, request access »

Chr. Olesen Synthesis Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 01-Jan-2011 000000000 Completed
  • 2 buyers
To view this company’s complete exits history, request access »

Chr. Olesen Synthesis Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Signet Healthcare Partners Growth/Expansion Minority 000 0000 000000 0

Chr. Olesen Synthesis Executive Team (2)

Name Title Board
Seat
Contact
Info
Erik Fischer Manager, API Development
Lone Nielsen Manager, Finance & Administration

Chr. Olesen Synthesis Board Members (2)

Name Representing Role Since Contact
Info
James Gale Signet Healthcare Partners Board Member 000 0000
Mads Olesen Chr. Olesen Synthesis Chairman 000 0000